Non-invasive prenatal testing for down's syndrome-where are we now

British Journal of Midwifery

Volumn 22, Issue 2, 2014, Pages 85-93

  Daley, Rebecca ^a   Hill, Melissa ^b   Lewis, Celine ^c   Chitty, Professor Lyn ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Hospital for Children NHS Foundation Trust   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902174302     PISSN: 09694900     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjom.2014.22.2.85     Document Type: Article

References (67)

1. American College of Obstetricians and Gynecologists (2012) Committee Opinion No. 545: Non-invasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology 120(6): 1532-4
2. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH (2012) Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. American Journal of Obstetrics and Gynecology 206(4): 322 e1-5
3. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH (2013) Trisomy 13 detection in the first trimester of pregnancy using a chromosomeselective cell-free DNA analysis method. Ultrasound in Obstetrics and Gynecology 41(1): 21-5
4. Benn P, Borrell A, Cuckle H, Dugoff L, Gross S, Johnson JA, Maymon R, Odibo A, Schielen P, Spencer K, Wright D, Yaron Y (2012) Prenatal detection of Down syndrome using massively parallel sequencing (MPS): a rapid response statement from a Committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenatal Diagnosis 32(1): 1-2
5. Benn P, Cuckle H, Pergament E (2013) Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound in Obstetrics and Gynecology 42(1): 15-33
6. Bianchi D (2010) From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood. Prenatal Diagnosis 30(7): 622-3
7. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group (2012) Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology 119(5): 890-901
8. Bot-Robin V, Sendon S, Bourzoufi K, Vaast P, Deken V, Dutoit P, Houfflin-Debarge V (2012) Maternal anxiety and pain during prenatal diagnostic techniques: A prospective study. Prenatal Diagnosis 32(6): 562-8
9. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE (2012) DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenatal Diagnosis 32(8): 730-4
10. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE (2013) The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenatal Diagnosis 33(7): 667-74
11. Chetty S, Garabedian MJ, Norton ME (2013) Uptake of non-invasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenatal Diagnosis 33(6): 542-6
12. Chitty LS, Finning G, Massey E, Soothill P, Daniels G (2011a) Antenatal determination of fetal rhesus (RH) D status using cell free fetal DNA in the maternal circulation before 20 weeks' gestation: Is routine application practical and beneficial? Archives of Disease in Childhood Fetal and Neonatal Edition 96(Supplement 1): Fa11-Fa12
13. Chitty LS, Griffin DR, Meaney C, Barrett A, Khalil A, Pajkrt E, Cole TJ (2011b) New aids for the non-invasive prenatal diagnosis of achondroplasia: Dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound in Obstetrics and Gynecology 37(3): 283-9
14. Chitty LS, Khalil A, Barrett AN, Pajkrt E, Griffin DR, Cole TJ (2013) Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenatal Diagnosis 33(5): 416-23
15. Dan S, Wang W, Ren J, Li Y, Hu H, Xu Z, Lau TK, Xie J, Zhao W, Huang H, Xie J, Sun L, Zhang X, Wang W, Liao S, Qiang R, Cao J, Zhang Q, Zhou Y, Zhu H, Zhong M, Guo Y, Lin L, Gao Z, Yao H, Zhang H, Zhao L, Jiang F, Chen F, Jiang H, Li S, Li Y, Wang J, Wang J, Duan T, Su Y, Zhang X (2012) Clinical application of massively parallel sequencing-based prenatal non-invasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenatal Diagnosis 32(13): 1225-32
16. Daniels G, Finning K, Martin P, Massey E (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: Current practice and future prospects. Prenatal Diagnosis 29(2): 101-7
17. Department of Health (2001) Chief Medical Officer's Update. 2001. Report No. 31: Down's syndrome screening.
18. Department of Health, London Department of Health (2003) Model of best practice for providing Down's syndrome Screening. Department of Health, London
19. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, McCullough R, McCarthy E, Nygren AO, Dean J, Tang L, Hutchison D, Lu T, Wang H, Angkachatchai V, Oeth P, Cantor CR, Bombard A, van den Boom D (2011) Non-invasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. American Journal of Obstetrics and Gynecology 204(3): 205 e1-e11
20. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ (2013) Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenatal Diagnosis 33(6): 569-74
21. Gottfredsdóttir H, Björnsdóttir K, Sandall J (2009) How do prospective parents who decline prenatal screening account for their decision? A qualitative study. Social Science and Medicine 69(2): 274-7
22. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS (2011) Non-invasive prenatal determination of fetal sex: Translating research into clinical practice. Clinical Genetics 80(1): 68-75
23. Hill M, Fisher J, Chitty LS, Morris S (2012) Women's and health professionals' preferences for prenatal tests for Down syndrome: A discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genetics in Medicine 14(11): 905-13
24. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW (2007) Early detection of cell-free fetal DNA in maternal plasma. Early Human Development 83(9): 563-6 (Pubitemid 47380125)
25. Kelly SE, Farrimond HR (2012) Non-invasive prenatal genetic testing: A study of public attitudes. Public Health Genomics 15(2): 73-81
26. Kontopoulos E, Odibo A, Wilson RD (2013) Current controversies in prenatal diagnosis 2: Are we ready to screen for fetal anomalies with first trimester ultrasound? Prenatal Diagnosis 33(1): 9-12
27. Lau TK, Jiang FM, Stevenson RJ, Lo TK, Chan LW, Chan MK, Lo PS, Wang W, Zhang HY, Chen F, Choy KW (2013) Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenatal Diagnosis 33(6): 602-8
28. Lewis C, Silcock C, Chitty LS (2013) Non-invasive prenatal testing for Down syndrome The views of pregnant women in the UK and their likely uptake. Public Health Genomics 16(5): 223-32
29. Lewis C, Hill M, Silcock C, Daley R, Chitty LS (2014) Non-invasive prenatal testing for trisomy 21: A crosssectional survey of service users' views and likely uptake. BJOG DOI: 10.1111/1471-0528.12579
30. Liang D, Lv W, Wang H, Xu L, Liu J, Li H, Hu L, Peng Y, Wu L (2013) Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenatal Diagnosis 33(5): 409-15
31. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076): 485-7 (Pubitemid 27343304)
32. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm M (1999) Rapid clearance of fetal DNA from maternal plasma. American Journal of Human Genetics 64(1): 218-24 (Pubitemid 30428975)
33. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, Chiu RW (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2(61): 61-91
34. Markens S, Browner CH, Press N (1999) 'Because of the risks': How US pregnant women account for refusing prenatal screening. Social Science and Medicine 49: 359-69 (Pubitemid 29281825)
35. Morris JK, Springett A (2013) The National Down Syndrome Cytogenetic Register for England and Wales: 2011 Annual Report. Queen Mary University of London, Barts and The London School of Medicine and Dentistry
36. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, Mol BW, van der Post JA, Khan KS (2008) Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysis. BMC Pregnancy and Childbirth 8: 33
37. Morris S, Karlsen S, Chung N, Hill M, Chitty LS (2013) Costs and outcomes of noninvasive prenatal testing for Down syndrome. Prenatal Diagnosis 33(Supplement 1): 6
38. NHS Fetal Anomaly Screening Programme (2012) NHS Fetal Anomaly Screening Programme. Annual report 2011-2012. NHS FASP, Exeter
39. Nicolaides KH (2011) Screening for fetal aneuploidies at 11 to 13 weeks. Prenatal Diagnosis 31(7): 7-15
40. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G (2012) Non-invasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. American Journal of Obstetrics and Gynecology 207(5): 374 e-6
41. Nicolaides H, Syngelaki A, Gil M, Atanasova V, Markova D (2013) Validation of targeted sequencing of singlenucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenatal Diagnosis 33(6): 575-9
42. Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, Rodriguez MH, Williams J 3rd, Mitchell ME, Adair CD, Lee H, Jacobsson B, Tomlinson MW, Oepkes D, Hollemon D, Sparks AB, Oliphant A, Song K (2012) Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetetrics and Gynecology 207(2): 137 e1-8
43. Oxenford K, Hill M, Chitty L (2012) Cell-free fetal DNA: Emerging applications and future obstacles. Expert Review of Obstetrics and Gynecology 7(6): 513-5
44. Oxenford K, Karunaratna M, Hill M, Taffinder S, Chitty L (2013) Progress in prenatal genetic diagnosis: Using cell-free fetal DNA in maternal blood. British Journal of Midwifery 21(2): 84-90
45. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA (2011) DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genetics in Medicine 13(11): 913-20
46. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genetics in Medicine 14(3): 296-305
47. Pan M, Li FT, Li Y, Jiang FM, Li DZ, Lau TK, Liao C (2013) Discordant results between fetal karyotyping and noninvasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenatal Diagnosis 33(6): 598-601
48. Sayres LC, Allyse M, Norton ME, Cho MK (2011) Cellfree fetal DNA testing: A pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis 31(11): 1070-6
49. Sayres LC, Allyse M, Cho MK (2012) Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy. Genome Medicine 4(6): 49
50. Searle CJ, Smith K, Daniels G, Maher EJ, Quarrell O (2013) Cell-free fetal DNA sex determination identified a maternal SRY gene with a known X chromosome deletion. Prenatal Diagnosis 33(6): 612-3
51. Seror V, Ville Y (2009) Prenatal screening for Down syndrome: Women's involvement in decision-making and their attitudes to screening. Prenatal Diagnosis 29(2): 120-8
52. Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, Zahn J, Lee K, Shen N, Doshi J, Sun M, Garrison J, Sandler J, Hollemon D, Pattee P, Tomita-Mitchell A, Mitchell M, Stuelpnagel J, Song K, Oliphant A. (2012a) Selective analysis of cellfree DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis 32(1): 3-9
53. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A (2012b) Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. American Journal of Obstetrics and Gynecology 206(4): 319 e1-9
54. Tabor A, Alfirevic Z (2010) Update on procedurerelated risks for prenatal diagnosis techniques. Fetal Diagnosis and Therapy 27(1): 1-7
55. Tapon D (2010) Prenatal testing for Down syndrome: Comparison of screening practices in the UK and USA. Journal of Genetic Counselling 19(2): 112-30
56. Taylor B, Chock VY, Hudgins L (2013) NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. Journal of Genetic Counselling [Epub ahead of print]
57. Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE (2011) Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenatal Diagnosis 31(13): 1292-9
58. Twiss P, Hill M, Daley R, Chitty LS (2014) Non-invasive prenatal testing for Down syndrome. Seminars in Fetal and Neonatal Medicine 19(1): 9-14
59. UK Clinical Research Network (2013a) NIPT for aneuploidy evaluation study. public.ukcrn.org.uk/search/StudyDetail. aspx?StudyID=13865 (accessed 13 January 2013)
60. UK Clinical Research Network (2013a) First-trimester cfDNA Testing. public.ukcrn.org.uk/Search/StudyDetail. aspx?StudyID=15084 (accessed 13 January 2013)
61. UK National Screening Committee (2011) NHS Fetal Anomaly Screening Programme. Screening for Down's syndrome: UK NSC Policy recommendations 2011-2014 Model of Best Practice. NHS FASP, Exeter
62. UK National Screening Committee (2013) Public Information Briefing-Non-Invasive Prenatal Testing (for Down's syndrome). UK National Screening Committee, London
63. Vahanian SA, Allaf MB, Yeh C, Chavez MR, Kinzler WL, Vintzileos AM (2014) Patient acceptance of non-invasive testing for fetal aneuploidy via cell-free fetal DNA. Journal of Maternal-Fetal and Neonatal Medicine 27(1): 106-9
64. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G (2005) Are pregnant women making informed choices about prenatal screening? Genetics in Medicine 7(5): 332-8 (Pubitemid 40827582)
65. Wald NJ, Bestwick JP (2013) Incorporating DNA sequencing into current prenatal screening practice for Down's syndrome. PLoS One 8(3): e58732
66. Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A (2013) Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenatal Diagnosis 33(7): 662-6
67. Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, Ryan A, Sigurjonsson S, Chopra N, Dodd M, Levy B, Rabinowitz M (2012) Non-invasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenatal Diagnosis 32(13): 1233-41